These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Association of serum C-reactive protein levels with lupus disease activity in the absence of measurable interferon-α and a C-reactive protein gene variant. Enocsson H, Sjöwall C, Kastbom A, Skogh T, Eloranta ML, Rönnblom L, Wetterö J. Arthritis Rheumatol; 2014 Jun; 66(6):1568-73. PubMed ID: 24574329 [Abstract] [Full Text] [Related]
5. CCR5Δ32 (rs333) polymorphism is associated with the susceptibility to systemic lupus erythematosus in female Brazilian patients. Baltus TH, Kallaur AP, Lozovoy MA, Morimoto HK, Delongui F, Alfieri DF, Iriyoda TM, Dichi I, Simão AN, Reiche EM. Rheumatol Int; 2016 Jan; 36(1):7-15. PubMed ID: 26071874 [Abstract] [Full Text] [Related]
6. Association of - 717 A > G (rs2794521) CRP polymorphism with high cardiovascular risk by C-reactive protein in systemic lupus erythematosus patients. Pesqueda-Cendejas K, Parra-Rojas I, Meza-Meza MR, Mora-García PE, Campos-López B, Ruiz-Ballesteros AI, Montoya-Buelna M, Rivera-Escoto M, Moreno-Ortiz JM, Bautista-Herrera LA, Cerpa-Cruz S, De la Cruz-Mosso U. Clin Rheumatol; 2023 Mar; 42(3):761-772. PubMed ID: 36355253 [Abstract] [Full Text] [Related]
7. The association of IL1α and IL1β polymorphisms with susceptibility to systemic lupus erythematosus: a meta-analysis. Wang B, Zhu JM, Fan YG, Feng CC, Chen GM, Chen H, Pan HF, Ye DQ. Gene; 2013 Sep 15; 527(1):95-101. PubMed ID: 23747396 [Abstract] [Full Text] [Related]
8. Interleukin 10 gene promoter polymorphisms (rs1800896, rs1800871 and rs1800872) and haplotypes are associated with the activity of systemic lupus erythematosus and IL10 levels in an Iranian population. Mohammadi S, Saghaeian Jazi M, Zare Ebrahimabad M, Eghbalpour F, Abdolahi N, Tabarraei A, Yazdani Y. Int J Immunogenet; 2019 Feb 15; 46(1):20-30. PubMed ID: 30430731 [Abstract] [Full Text] [Related]
9. CD14 (C-159T) polymorphism is associated with increased susceptibility to SLE, and plasma levels of soluble CD14 is a novel biomarker of disease activity: A hospital-based case-control study. Panda AK, Tripathy R, Das BK. Lupus; 2021 Feb 15; 30(2):219-227. PubMed ID: 33176568 [Abstract] [Full Text] [Related]
10. Toll-like receptor 4 gene polymorphism 1196 C/T does not influence the risk of neuropsychiatric systemic lupus erythematosus in Polish population--a preliminary report. Bogaczewicz A, Sobow T, Bogaczewicz J, Kaleta B, Sysa-Jedrzejowska A, Robak E, Lukaszkiewicz J, Dariusz S, Wozniacka A. Lupus; 2013 Dec 15; 22(14):1504-8. PubMed ID: 24243911 [Abstract] [Full Text] [Related]
11. The association of CD40 polymorphism (rs1883832C/T) and soluble CD40 with the risk of systemic lupus erythematosus among Egyptian patients. Mousa TG, Omar HH, Emad R, Salama MI, Omar W, Fawzy M, Hassoba HM. Clin Rheumatol; 2019 Mar 15; 38(3):777-784. PubMed ID: 30374748 [Abstract] [Full Text] [Related]
12. Investigation of rs531564 Polymorphism in the Primary MicroRNA-124 Gene in Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis: Association with Disease Susceptibility and Clinical Characteristics. Hassani M, Dehani M, Zare Rafie M, Esmaeilzadeh E, Davar S, Pakzad B, Mosallaei M, Hoseini SM, Bayat H, Soosanabadi M. Iran J Allergy Asthma Immunol; 2021 Jun 06; 20(3):303-313. PubMed ID: 34134452 [Abstract] [Full Text] [Related]
14. Polymorphisms of the folate metabolizing enzymes: Association with SLE susceptibility and in silico analysis. Salimi S, Keshavarzi F, Mohammadpour-Gharehbagh A, Moodi M, Mousavi M, Karimian M, Sandoughi M. Gene; 2017 Dec 30; 637():161-172. PubMed ID: 28943344 [Abstract] [Full Text] [Related]
15. PTPN22 1858C > T polymorphism and susceptibility to systemic lupus erythematosus: a meta-analysis update. de Lima SC, Adelino JE, Crovella S, de Azevedo Silva J, Sandrin-Garcia P. Autoimmunity; 2017 Nov 30; 50(7):428-434. PubMed ID: 28990435 [Abstract] [Full Text] [Related]
17. The -675 4G/5G PAI-1 polymorphism confers genetic susceptibility to systemic lupus erythematosus, its clinical manifestations, and comorbidities in Mexican-Mestizo population. Anaya-Macias BU, De la Cruz-Mosso U, Palafox-Sánchez CA, Parra-Rojas I, Martínez-Bonilla G, González-López L, Gámez-Nava JI, Pérez-Guerrero EE, Barrientos-Avalos SL, Muñoz-Valle JF. Autoimmunity; 2020 Mar 30; 53(2):71-77. PubMed ID: 31829037 [Abstract] [Full Text] [Related]
19. Association between 318C/T polymorphism of the CTLA-4 gene and systemic lupus erythematosus in Iranian patients. Shojaa M, Aghaie M, Amoli M, Javid N, Shakeri F, Khashayar P, Tabarraei A, Keshtkar AA, Joshaghani HR, Kouroshnia A, Qorbani M, Mahmoudi F, Mohebbi R, Ranjbarpour N. Int J Rheum Dis; 2017 Dec 30; 20(12):2040-2044. PubMed ID: 24400885 [Abstract] [Full Text] [Related]